Dog Epilepsy Long-Term Management

Canine epilepsy requires lifelong anticonvulsant therapy in most cases, and optimising seizure control while minimising medication side effects is central to long-term welfare.

Key Facts

Idiopathic epilepsy is the most common neurological disorder in dogs, with some breeds at high genetic risk
First-line anticonvulsants include phenobarbitone, potassium bromide, and imepitoin
Treatment is typically initiated after a second seizure or when first seizures are severe or clustered
Therapeutic drug monitoring guides dose optimisation and minimises toxicity risk
Cluster seizures and status epilepticus are acute emergencies requiring immediate intervention
Drug-resistant epilepsy affects a subset of dogs and requires combination anticonvulsant therapy

Welfare Considerations

Epileptic dogs experience acute welfare harm during seizure events through the physical injury risk, post-ictal disorientation, and the physiological distress of uncontrolled neuronal discharge. Poorly controlled epilepsy with frequent seizures substantially reduces quality of life. Anticonvulsant side effects including sedation, ataxia, and polyphagia also affect welfare and must be managed alongside seizure control. The goal of management is the fewest and least severe seizures achievable with the minimum medication burden, enabling dogs to live active and engaged lives. Regular monitoring and willingness to adjust treatment is essential.

What You Can Do

Begin anticonvulsant treatment promptly after your vet recommends it; delay worsens long-term outcomes
Maintain a seizure diary recording date, duration, and character to guide treatment adjustments
Attend regular therapeutic drug monitoring appointments to maintain optimal anticonvulsant levels
Know how to recognise cluster seizures and status epilepticus and when to use emergency diazepam
Support canine epilepsy genetic research in predisposed breeds to enable breeding selection against the condition